Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 12016842 Methods of using anti-CD79b immunoconjugates

Patent 12016842 was granted and assigned to Genentech on June, 2024 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Current Assignee
Genentech
Genentech
0
Date Filed
April 14, 2021
0
Date of Patent
June 25, 2024
0
Patent Applicant
Genentech
Genentech
0
Patent Application Number
17230861
0
Patent Citations
‌
US Patent 7091186 None
0
‌
US Patent 7097840 Methods of treatment using anti-ErbB antibody-maytansinoid conjugates
0
‌
US Patent 7098305 Sustained release of microcrystalline peptide suspensions
0
‌
US Patent 7098308 Pentapeptide compounds and uses related thereto
0
‌
US Patent 7202346 Antibodies to non-shed Muc1 and Muc16, and uses thereof
0
‌
US Patent 7276372 Antibodies against GPR64 and uses thereof
0
‌
US Patent 7288248 Antibodies against cancer antigen TMEFF2 and uses thereof
0
‌
US Patent 7303749 Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents
0
‌
US Patent 7312343 Synthesis of α-amino-β-alkoxy-carboxylic acid esters
0
‌
US Patent 7375078 Heterocyclic self-immolative linkers and conjugates
0
•••
Patent Inventor Names
Dan Lu
0
Jamie Harue Hirata
0
Yu-Waye Chu
0
Shang-Fan Yu
0
Michael Wenger
0
Andrew Polson
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
12016842
0
Patent Primary Examiner
‌
Sheela J. Huff
0
CPC Code
‌
C07K 16/2887
0
‌
A61K 2300/00
0
‌
A61K 39/39558
0
‌
A61P 35/00
0
‌
A61K 47/6889
0
‌
C07K 16/3061
0

Find more entities like US Patent 12016842 Methods of using anti-CD79b immunoconjugates

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.